Literature DB >> 16537767

Over 20,000 avoidable coronary deaths in England and Wales in 2000: the failure to give effective treatments to many eligible patients.

S Capewell, B Unal, J A Critchley, J J V McMurray.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16537767      PMCID： PMC1860878          DOI： 10.1136/hrt.2004.053645

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  4 in total

1.  Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994.

Authors:  S Capewell; C E Morrison; J J McMurray
Journal:  Heart       Date:  1999-04       Impact factor: 5.994

2.  Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.

Authors: 
Journal:  Eur Heart J       Date:  2001-04       Impact factor: 29.983

3.  Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000.

Authors:  Belgin Unal; Julia Alison Critchley; Simon Capewell
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

4.  Missing, mediocre, or merely obsolete? An evaluation of UK data sources for coronary heart disease.

Authors:  B Unal; J A Critchley; S Capewell
Journal:  J Epidemiol Community Health       Date:  2003-07       Impact factor: 3.710
  4 in total
  6 in total

1.  Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America.

Authors:  Simon Capewell; Earl S Ford; Janet B Croft; Julia A Critchley; Kurt J Greenlund; Darwin R Labarthe
Journal:  Bull World Health Organ       Date:  2009-12-08       Impact factor: 9.408

2.  Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006.

Authors:  Thor Aspelund; Vilmundur Gudnason; Bergrun Tinna Magnusdottir; Karl Andersen; Gunnar Sigurdsson; Bolli Thorsson; Laufey Steingrimsdottir; Julia Critchley; Kathleen Bennett; Martin O'Flaherty; Simon Capewell
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

3.  Socioeconomic and ethnic differences in use of lipid-lowering drugs after deregulation of simvastatin in the UK: the Whitehall II prospective cohort study.

Authors:  Ian Forde; Tarani Chandola; Rosalind Raine; Michael G Marmot; Mika Kivimaki
Journal:  Atherosclerosis       Date:  2010-12-21       Impact factor: 5.162

4.  Trends in longer-term survival following an acute myocardial infarction and prescribing of evidenced-based medications in primary care in the UK from 1991: a longitudinal population-based study.

Authors:  Sarah L Hardoon; Peter H Whincup; Irene Petersen; Simon Capewell; Richard W Morris
Journal:  J Epidemiol Community Health       Date:  2010-06-01       Impact factor: 3.710

5.  Population assessment of future trajectories in coronary heart disease mortality.

Authors:  Rosa Björk Thorolfsdottir; Thor Aspelund; Simon Capewell; Julia Critchley; Vilmundur Gudnason; Karl Andersen
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

6.  Explaining the decline in coronary heart disease mortality in Turkey between 1995 and 2008.

Authors:  Belgin Unal; Kaan Sözmen; Hale Arık; Gül Gerçeklioğlu; Deniz Utku Altun; Hatice Şimşek; Sinem Doganay; Yücel Demiral; Özgür Aslan; Kathleen Bennett; Martin O'Flaherty; Simon Capewell; Julia Critchley
Journal:  BMC Public Health       Date:  2013-12-05       Impact factor: 3.295
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.